Risperidone, olanzapine, ziprasidone, and quetiapine, as a group, appear as effective as typical (older) antipsychotic medications using control a positive symptoms as the endpoint.

Administration least likely to induce metabolic side effects:

Compared to the typical antipsychotic medications, atypical antipsychotic agents exhibit fewer treatment-emergent antidopaminergic-related side effects.

This antipsychotic medication is classified as a partial dopamine agonist.

For management of acute phase schizophrenia: which one(s) of the following atypical antipsychotics is/are appropriate?

Following agitation control in patients presenting in acute phase schizophrenia, which one(s) of the following agents, orally administered, might be LEAST appropriate in never-treated her medication-free individuals with a history of response to antipsychotic medication treatment?

In individuals without psychiatric illness given antipsychotic medications, impaired performance in psychomotor and psychometric tests are typically observed.

Elevation of prolactin levels is least likely associated with this relatively newer antipsychotic agent:

Administration of lower-potency phenothiazines (typical anti-psychotic drugs [older]) often result in orthostatic hypotension (postural hypotension) and reflex tachycardia.

Factor/factors involved in antipsychotic drug choice for long-term schizophrenia management: